Slide 1 A Phase III, Randomized, Double-Blind, Placebo-Controlled Registration Trial to Evaluate the Efficacy and Safety of Placebo + Trastuzumab + Docetaxel vs. Pertuzumab…
7/14/2019 Post as Co 2013 Trujillo 1/46MAMA DISEMINADARAFAEL TRUJILLO VILCHEZPOST-ASCO 20137/14/2019 Post as Co 2013 Trujillo 2/46Efficacy and safety of first-line pertuzumab,trastuzumab,…